Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(11%)
Results Posted
0%(0 trials)

Phase Distribution

Ph early_phase_1
1
11%
Ph not_applicable
6
67%
Ph phase_1
2
22%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Early Phase 1First-in-human
1(11.1%)
Phase 1Safety & dosage
2(22.2%)
N/ANon-phased studies
6(66.7%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(4)
Other(4)

Detailed Status

Completed4
unknown4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Early Phase 11 (11.1%)
Phase 12 (22.2%)
N/A6 (66.7%)

Trials by Status

completed444%
unknown444%
active_not_recruiting111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
9